← Back to Screener
Inogen Inc (INGN)
Price$6.09
Value ScoreB
Growth ScoreD
Momentum ScoreC
Favorite Metrics
Price vs S&P 500 (26W)-17.45%
Price vs S&P 500 (4W)-11.99%
VGM Score53.73
Market Capitalization$173.28M
All Metrics
P/CF (Annual)29.56x
Book Value / Share (Quarterly)$6.68
P/TBV (Annual)1.13x
Indicated Dividend (Annual)$0.00
Revenue Growth (3Y)-2.59%
Cash Flow / Share (Quarterly)$-0.37
Price vs S&P 500 (YTD)-14.36%
Gross Margin (TTM)44.31%
Net Profit Margin (TTM)-7.08%
EPS (TTM)$-0.92
10-Day Avg Trading Volume0.34M
EPS Excl Extra (TTM)$-0.92
Revenue Growth (5Y)2.48%
EPS (Annual)$-0.86
ROI (Annual)-11.83%
Gross Margin (Annual)44.24%
Net Profit Margin (5Y Avg)-14.73%
Cash / Share (Quarterly)$4.03
Revenue Growth QoQ (YoY)3.44%
ROA (Last FY)-7.62%
Revenue Growth TTM (YoY)3.39%
EBITD / Share (TTM)$-0.42
ROE (5Y Avg)-22.47%
Operating Margin (TTM)-9.07%
Cash Flow / Share (Annual)$-0.79
P/B Ratio0.95x
P/B Ratio (Quarterly)0.92x
Net Income / Employee (Annual)$-30,200
EV / Revenue (TTM)0.23x
Net Interest Coverage (TTM)26.25x
ROA (TTM)-8.27%
EV / EBITDA (TTM)13.14x
EPS Incl Extra (Annual)$-0.86
Current Ratio (Annual)3.12x
Quick Ratio (Quarterly)2.50x
3-Month Avg Trading Volume0.31M
52-Week Price Return-0.61%
Revenue / Employee (TTM)$466,800
Tangible BV / Share (Quarterly)$5.63
P/S Ratio (Annual)0.50x
Asset Turnover (Annual)1.17x
52-Week High$9.13
Operating Margin (5Y Avg)-15.20%
EPS Excl Extra (Annual)$-0.86
CapEx CAGR (5Y)-10.02%
Tangible BV CAGR (5Y)-10.48%
26-Week Price Return-1.52%
Quick Ratio (Annual)2.51x
13-Week Price Return0.78%
Total Debt / Equity (Annual)0.00x
Current Ratio (Quarterly)3.10x
Enterprise Value$80.16M
Revenue / Share Growth (5Y)-1.34%
Asset Turnover (TTM)1.17x
Book Value / Share Growth (5Y)-14.91%
Revenue / Employee (Annual)$463,000
Inventory Turnover (Annual)7.66x
Pretax Margin (Annual)-6.71%
Cash / Share (Annual)$4.39
3-Month Return Std Dev43.93%
Gross Margin (5Y Avg)44.09%
Net Income / Employee (TTM)$-33,100
ROE (Last FY)-11.83%
Net Interest Coverage (Annual)13.86x
EPS Basic Excl Extra (Annual)$-0.86
P/FCF (TTM)318.52x
Receivables Turnover (TTM)8.96x
Total Debt / Equity (Quarterly)0.00x
EPS Incl Extra (TTM)$-0.92
Receivables Turnover (Annual)10.19x
ROI (TTM)-12.90%
P/S Ratio (TTM)0.49x
Pretax Margin (5Y Avg)-13.93%
Revenue / Share (Annual)$13.11
Tangible BV / Share (Annual)$5.93
Price vs S&P 500 (52W)-28.82%
Year-to-Date Return-3.42%
5-Day Price Return1.41%
EPS Normalized (Annual)$-0.86
ROA (5Y Avg)-14.63%
Net Profit Margin (Annual)-6.52%
Month-to-Date Return-8.72%
Cash Flow / Share (TTM)$-5.02
EBITD / Share (Annual)$-0.95
Operating Margin (Annual)-8.66%
LT Debt / Equity (Annual)0.00x
ROI (5Y Avg)-22.47%
LT Debt / Equity (Quarterly)0.00x
EPS Basic Excl Extra (TTM)$-0.92
P/TBV (Quarterly)1.09x
P/B Ratio (Annual)0.95x
Inventory Turnover (TTM)7.64x
Pretax Margin (TTM)-7.28%
Book Value / Share (Annual)$7.06
Price vs S&P 500 (13W)-8.97%
Beta1.61x
P/FCF (Annual)8.93x
Revenue / Share (TTM)$12.86
ROE (TTM)-12.90%
52-Week Low$5.34
vGradeB
gGradeD
mGradeC
vgmGradeC
Show chart for
Earnings Surprise History
Q1 26-0.30est. -0.29
Analyst Recommendations
Feb 2026
Mar 2026
Apr 2026
May 2026
4.13
4.13
4.13
4.11
Industry Peers — Orthopedic & Prosthetic Devices(33)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
INGNInogen Inc | B | D | C | $6.09 |
| ISRGIntuitive Surgical Inc. | D | B | D | $412.26 |
| EWEdwards Lifesciences Corp | D | C | C | $88.16 |
| STESTERIS plc | C | B | D | $211.07 |
| ZBHZimmer Biomet Holdings, Inc. | B | C | D | $82.94 |
| ALGNAlign Technology Inc | C | C | C | $169.77 |
| SNNSmith & Nephew plc | B | C | C | $29.48 |
| MSAMine Safety Incorporated | C | C | C | $163.13 |
| ESTAEstablishment Labs Holdings Inc. | F | A | B | $68.08 |
| CDRECadre Holdings, Inc. | C | C | D | $30.62 |
| ENOVEnovis Corporation | B | D | D | $21.70 |
About
Inogen Inc develops and manufactures respiratory care products for patients with chronic respiratory conditions, including portable and stationary oxygen concentrators, airway clearance devices, and CPAP masks. The company generates revenue through product sales and equipment rental services across its respiratory health solutions portfolio.